Our unbiased analysis of key genes and pathways suggests that ZBC260 negatively regulates breast cancer stemness by suppressing key inflammatory molecules and STAT genes, associated with the JAK-STAT signaling pathway known to be involved in driving the cancer stem cell (CSC) phenotype. Here, SOAT1 is linked to breast cancer.